Bacteremia in HIV-positive and AIDS Patients: Incidence, Species Distribution, Risk-factors, Outcome, and Influence of Long-term Prophylactic Antibiotic Treatment

1994 ◽  
Vol 26 (6) ◽  
pp. 635-642 ◽  
Author(s):  
Christian N. Meyer ◽  
Peter Skinhøj ◽  
Jørgen Prag
Keyword(s):  
Risk Factors ◽  
Antibiotic Treatment ◽  
Species Distribution ◽  
Prophylactic Antibiotic ◽  
Hiv Positive ◽  
Aids Patients ◽  
Prophylactic Antibiotic Treatment

scholarly journals Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in southwestern China: a cohort study

2020 ◽  
Author(s):  
Yunxuan Huang ◽  
Oulu Zhou ◽  
Zhigang Zheng ◽  
Yuexiang Xu ◽  
Yi Shao ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cohort Study ◽  
Antiretroviral Therapy ◽  
Mortality Risk ◽  
Hiv Positive ◽  
Aids Patients ◽  
Death Risk ◽  
Long Term Mortality ◽  
Hiv Aids

Abstract Objective To evaluate the impact of AIDS-defining events (ADE) on long-term mortality of HIV positive individuals on antiretroviral therapy (ART), a retrospective HIV/AIDS treatment cohort study was performed in southwestern China. Methods The cohort was established based on HIV/AIDS patients on ART recruited in Guigang city, Guangxi, China, from January 2004 to December 2018. Participants were divided into ADE and non-ADE groups, and were followed-up every six months to observe treatment outcomes. Comparison of mortality between groups was performed using the log-rank test and Kaplan-Meier analysis. Cox proportional hazard regression was used to explore the risk factors of mortality. 1:1 propensity score matching (PSM) was used to balance confounding factors and adjust the mortality risk. Results Of 6,757 participants with 29,096.06 person-years of follow-up, 16.86% (1,139/6,757) belonged to ADE group while the others (83.14%) belonged to the non-ADE group. The most common cause of death by ADE was disseminated mycosis (31.65%), followed by recurrent severe bacterial pneumonia (28.48%), herpes zoster(17.72%), and extra-pulmonary tuberculosis (8.86%). The mortality of the ADE group was significantly higher than that of the non-ADE group [3.45/100 person-years (95% CI: 2.92-3.97) vs. 2.34/100 person-years (95%CI: 2.15-2.52), P<0.001]. The death risk of the ADE group was also higher than that of the non- ADE group [adjusted hazard ratio (aHR) =1.291, 95% CI: 1.061-1.571, P =0.011], which was confirmed by PSM analysis (aHR=1.581, 95% CI: 1.192-2.099, P =0.002). Cox analysis indicated that ADE, older age, male gender, previous non-use of cotrimoxazole, advanced WHO clinical stage, and low baseline CD4+ cell count were the risk factors for death. Conclusions Even on ART, the mortality risk of HIV positive individuals with ADE was higher than those without ADE. Active testing, earlier diagnosis, and timely therapy with ART may reduce the death risk of ADE.

The effect of prophylactic antibiotic treatment for manual removal of the placenta on frequency of postpartum endometritis

2017 ◽  
Vol 139 (1) ◽  
pp. 45-49 ◽  
Author(s):  
Myriam Safrai ◽  
Doron Kabiri ◽  
Rani Haj-Yahya ◽  
Adi Reuveni-Salzman ◽  
Michal Lipschuetz ◽  
...  
Keyword(s):  
Antibiotic Treatment ◽  
Prophylactic Antibiotic ◽  
Manual Removal ◽  
Prophylactic Antibiotic Treatment

Prophylactic Antibiotic Reduces the Risk of Peritonitis after Invasive Gynecologic Procedures

2019 ◽  
Vol 39 (4) ◽  
pp. 356-361
Author(s):  
Pei-Yi Fan ◽  
Ming-Jen Chan ◽  
Sheng-Hsuan Lin ◽  
Hsin-Hsu Wu ◽  
Ming-Yang Chang ◽  
...  
Keyword(s):  
Antibiotic Treatment ◽  
Medical Center ◽  
Demographic Data ◽  
Group B Streptococcus ◽  
Prophylactic Antibiotic ◽  
Antibiotic Use ◽  
Streptococcus Group ◽  
Prophylactic Antibiotic Treatment ◽  
Group B ◽  
Invasive Techniques

BackgroundPeritonitis is a serious complication after invasive procedures in patients undergoing peritoneal dialysis (PD). Most studies that have investigated peritonitis following invasive gynecologic procedures enrolled small patient populations. This study focuses on the clinical presentation, outcomes, and effects of prophylactic antibiotic use before invasive techniques.MethodsA retrospective study was conducted on patients who underwent invasive gynecologic procedures between 2005 and 2015 in a tertiary medical center. Eligible patients were identified and enrolled and their demographic data were collected. The use of prophylactic antibiotics and the outcomes of peritonitis were recorded.ResultsTwenty-six gynecologic procedures were performed on 18 PD patients. Seven episodes of peritonitis occurred in 6 patients after invasive gynecologic procedures. Eleven procedures were preceded by prophylactic antibiotic treatment (6 oral cefadroxil, 1 oral cefuroxime, 1 oral clindamycin, 1 intravenous [IV] ceftriaxone, 1 IV ceftazidime, and 1 IV cefazolin). The pathogens were diverse (group B Streptococcus, group D Streptococcus, E. coli, and Enterococcus). All episodes of peritonitis were successfully treated using intraperitoneal antibiotics without recurrence, technique failure, or mortality. The odds ratio of peritonitis in the non-prophylaxis group was 20.29 (95% confidence interval 1.01 – 406.35, p = 0.0103).ConclusionThe use of prophylactic antibiotic treatment considerably reduced the risk of peritonitis after invasive gynecologic procedures.

Prophylactic Antibiotic Treatment Prevents Infection after Cardiopulmonary Bypass: A Study in Dogs

1987 ◽  
Vol 43 (5) ◽  
pp. 544-549 ◽  
Author(s):  
Willem van Oeveren ◽  
Jacob Dankert ◽  
Walter Wildevuur ◽  
Charles R.H. Wildevuur
Keyword(s):  
Cardiopulmonary Bypass ◽  
Antibiotic Treatment ◽  
Prophylactic Antibiotic ◽  
Prophylactic Antibiotic Treatment
Sign in / Sign up

Export Citation Format

Share Document